Browse Drug Recalls

1,110 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 1,110 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 1,110 FDA drug recalls in CA.

Clear
DateProductReasonClassFirm
May 7, 2012 Rodan & Fields Proactiv Solution, Sheer Finish Compact Foundation, salicylic ... Subpotent Drug: Salicylic acid is subpotent. Class III Guthy-Renker LLC
May 7, 2012 Rodan & Fields Proactiv Solution, Sheer Finish Compact Foundation, salicylic ... Subpotent Drug: Salicylic acid is subpotent. Class III Guthy-Renker LLC
May 7, 2012 Rodan & Fields Proactiv Solution, Sheer Finish Compact Foundation, salicylic ... Subpotent Drug: Salicylic acid is subpotent. Class III Guthy-Renker LLC
Apr 17, 2012 Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle,... Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used... Class III Watson Laboratories Inc
Apr 17, 2012 Loxapine Capsules USP, 25mg, 100 count bottle, Rx only, Manufactured By: Wats... Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used... Class III Watson Laboratories Inc
Apr 17, 2012 Loxapine Capsules USP, 10mg, 100 count bottle, Rx only, Manufactured By: Wats... Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used... Class III Watson Laboratories Inc
Apr 17, 2012 Loxapine Capsules USP, 50mg, 100 count bottle, Rx only Manufactured By: Watso... Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used... Class III Watson Laboratories Inc
Apr 17, 2012 Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson... Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used... Class III Watson Laboratories Inc
Dec 19, 2011 Actra-SX 500 Capsules, Maximum Strength, Energizer, 500 mg, 5 count package, ... Marketed without an Approved NDA/ANDA; product contains sildenafil, an active ingredient in a FDA... Class I Body Basics Inc
Mar 1, 2010 Eye Drops advanced relief (Dextran 70 0.1%, Polyethylene glycol 400 1%, Povid... Labeling: Label Mix-Up: Incorrect back labeling of the immediate container of eye drops (unit car... Class II K C Pharmaceuticals Inc

Frequently Asked Questions

When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.